Abstract
A critical dose of apomorphine (300 μg/kg SC) given immediately before placing rats into a novel environment produced a diphasic motility response (initial sedation followed by enhanced locomotion). Various neuroleptics having different clinical and/or pharmacological profiles were studied by using such a model. (−)-Sulpiride and sultopride preferentially antagonized apomorphine inhibition; haloperidol and tiapride antagonized both phases of apomorphine response at similar doses; chlorpromazine, fluphenazine, thioridazine, metoclopramide and SCH 23390 preferentially antagonized apomorphine stimulation. The results are discussed in terms of the dopamine receptor subtypes involved in the two phases of apomorphine effect. Apomorphine stimulation can be antagonized by D-1 as well as D-2 receptor blockade. A higher affinity for D-2 receptors seems a necessary requisite for the antagonism of apomorphine inhibition; moreover, the ability of neuroleptics to antagonize apomorphine inhibition seems to depend on the ratio of their presynaptic versus postsynaptic D-2 activity.
Similar content being viewed by others
References
Anden NE, Strömbom U, Svensson TH (1973) Dopamine and noradrenaline receptor stimulation: reversal of reserpine-induced suppression of motor activity. Psychopharmacologia 29:289–298
Boyce S, Kelly E, Davis A, Fleminger S, Jenner P, Marsden CD (1985) SCH 23390 may alter dopamine-mediated motor behaviour via striatal D-1 receptors. Biochem Pharmacol 34:1665–1669
Carlsson A (1975) Receptor-mediated control of dopamine metabolism. In: Usdin E, Bunney VE (eds) Pre- and postsynaptic receptors. Marcel Dekker, New York, pp 49–65
Christensen AV, Arnt J, Hyttel J, Larsen JJ, Svendsen O (1984) Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neuroleptics. Life Sci 34:1529–1540
Di Chiara G, Porceddu ML, Vargiu L, Argiolas A, Gessa GL (1976) Evidence for dopamine receptors mediating sedation in the mouse brain. Nature 264:564–567
Fleminger S, Van de Waterbeemd H, Rupniak NM, Reavill C, Testa B, Jenner P, Marsden CD (1983) Potent lipophilic substituted benzamides drugs are not selective D-1 dopamine receptor antagonists in the rat. J Pharm Pharmacol 35:363–368
Gessa GL, Porceddu ML, Collu M, Mereu G, Serra M, Ongini E, Biggio G (1985) Sedation and sleep induced by high doses of apomorphine after blockade of D-1 receptors by SCH 23390. Eur J Pharmacol 109:269–274
Hyttel J (1983) SCH 23390 — the first selective dopamine D1 antagonist. Eur J Pharmacol 91:153–154
Iorio LC, Barnett A, Leitz FH, Houser VP, Korduba CA (1983) SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems. J Pharmacol Exp Ther 226:462–468
Kebabian JW, Calne DB (1979) Multiple receptors for dopamine. Nature 277:93–96
Maj J, Grabowska M, Gajda L (1972) Effect of apomorphine on motility in rats. Eur J Pharmacol 17:208–214
Meller E, Kuga S, Friedhoff AJ, Goldstein M (1985) Selective D2 dopamine receptor agonists prevent catalepsy induced by SCH 23390, a selective D1 antagonist. Life Sci 36:1857–1864
Molloy AG, Waddington JL (1984) Dopaminergic behaviour stereospecifically promoted by the D1 agonist R-SK & F 38393 and selectively blocked by the D1 antagonist SCH 23390. Psychopharmacology 82:409–410
Montanaro N, Vaccheri A, Dall'Olio R, Gandolfi O (1983) Time course of rat motility response to apomorphine: a simple model for studying preferential blockade of brain dopamine receptors mediating sedation. Psychopharmacology 81:214–219
Robertson A, MacDonald C (1985) Opposite effects of sulpiride and metoclopramide on amphetamine-induced stereotypy. Eur J Pharmacol 109:81–89
Seeman P (1980) Brain dopamine receptors. Pharmacol Rev 32:229–313
Author information
Authors and Affiliations
Additional information
Offprint requests to: N. Montanaro
Rights and permissions
About this article
Cite this article
Vaccheri, A., Dall'Olio, R., Gandolfi, O. et al. Involvement of different dopamine receptors in rat diphasic motility response to apomorphine. Psychopharmacology 89, 265–268 (1986). https://doi.org/10.1007/BF00174356
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00174356